Date

14 Sep 2022
Expired!

Time

6:30 pm - 8:30 pm

FORXIGA® (dapagliflozin) – TRANSFORMING TREATMENT IN CKD

The meeting aims to facilitate discussion around the
challenges of diagnosis and management of Chronic Kidney Disease (CKD) in primary care, with a focus on new clinical evidence, indications and treatment guidelines. It aims to help you identify patients at risk of CKD and which patients may be suitable for treatment with FORXIGA® (dapagliflozin)

VENUE: Victoria Park Function Venue – Alabaster Room
309 Herston Road
Herston, QLD 4006

REPRESENTATIVE: Samantha Wicks
Phone: 0466 297 833
Email: samantha.wicks@astrazeneca.com

SUMMARY LINK with LOCATION MAP: https://web.cvent.com/event/ed19c5ee-d3e9-4d49-9207-4b3ac6a336a4/summarySummary – FORXIGA® (dapagliflozin): Transforming Treatment in CKD (cvent.com)

REGISTRATION LINK: 
https://web.cvent.com/event/ed19c5ee-d3e9-4d49-9207-4b3ac6a336a4/regProcessStep1

Comments are closed.

Website feedback or support